Vector-born disease models are extensively used for surveillance and control processes. The most simple and generally use model (SEIR-SEI model) cannot explain a variety of phenomena involved in these diseases spread and development. In order to obtain a wider insight of the vector-born disease models (and the dynamics involved in them), this work focuses into analyse the classical model, a modified versions of it, and 8 their parameters. The modified version includes host mobility, 9 environmental, re-susceptibility, and mosquito life cycle considerations. As results it is observed that there are a limiting number of parameters that play the most important roles in the dynamics (those related to mortality rates, recovery rate from infectious, and pathogen transmission probabilities). Therefore, parameters determination should focus primarily into estimate these values. Stronger effects of the environmental variables are observed and expected by using different parameters and/or the use of multiple environmental variable at the same time.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479329PMC
http://dx.doi.org/10.1016/j.heliyon.2020.e04090DOI Listing

Publication Analysis

Top Keywords

disease models
12
vector-born disease
8
multi-cluster environmental
4
environmental dependant
4
dependant vector
4
vector born
4
born disease
4
models vector-born
4
models extensively
4
extensively surveillance
4

Similar Publications

Objective: There is a lack of consensus regarding the optimal antithrombotic therapy (ATT) after popliteal and infrapopliteal (PIP) endovascular therapy (EVT). Currently, dual antiplatelet therapy (DAPT) for 3 months and single antiplatelet therapy (SAPT) are the most prescribed regimens in the Netherlands. Thus far, no randomized comparison has been performed on the optimal ATT approach.

View Article and Find Full Text PDF

Background: Tracheal, bronchial, and lung cancers (TBL cancers) pose a significant global health challenge, with rising incidence and mortality rates, particularly in China. Studies from the Global Burden of Disease (GBD), 2021, can guide screening and prevention strategies for TBL cancer. This study aims to provide a comprehensive analysis of the burden of TBL cancers in China compared to global data.

View Article and Find Full Text PDF

MicroRNAs (miRNAs) are associated with amyloid-β (Aβ) dysmetabolism, a pivotal factor in the pathogenesis of Alzheimer's disease (AD). This study unveiled a novel miRNA, microRNA-32533 (miR-32533), featuring a distinctive base sequence identified through RNA sequencing of the APPswe/PSEN1dE9 (APP/PS1) mouse brain. Its role and underlying mechanisms were subsequently explored.

View Article and Find Full Text PDF

Therapeutic Black Phosphorus Nanosheets Elicit Neutrophil Response for Enhanced Tumor Suppression.

Adv Sci (Weinh)

January 2025

Department of General Surgery, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, P. R. China.

Black phosphorus (BP) has demonstrated potential as a drug carrier and photothermal agent in cancer therapy; however, its intrinsic functions in cancer treatment remain underexplored. This study investigates the immunomodulatory effects of polyethylene glycol-functionalized BP (BP-PEG) nanosheets in breast cancer models. Using immunocompetent mouse models-including 4T1 orthotopic BALB/c mice and MMTV-PyMT transgenic mice, it is found that BP-PEG significantly inhibits tumor growth and metastasis without directly inducing cytotoxicity in tumor cells.

View Article and Find Full Text PDF

An oral microbiota-based deep neural network model for risk stratification and prognosis prediction in gastric cancer.

J Oral Microbiol

January 2025

Integrative Microecology Clinical Center, Shenzhen Clinical Research Center for Digestive Disease, Shenzhen Technology Research Center of Gut Microbiota Transplantation, The Clinical Innovation & Research Center, Shenzhen Key Laboratory of Viral Oncology, Department of Clinical Nutrition, Shenzhen Hospital, Southern Medical University, Shenzhen, China.

Background: This study aims to develop an oral microbiota-based model for gastric cancer (GC) risk stratification and prognosis prediction.

Methods: Oral microbial markers for GC prognosis and risk stratification were identified from 99 GC patients, and their predictive potential was validated on an external dataset of 111 GC patients. The identified bacterial markers were used to construct a Deep Neural Network (DNN) model, a Random Forest (RF) model, and a Support Vector Machine (SVM) model for predicting GC prognosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!